Healthcare Dec 28, 2021 10:50 AM (GMT+8) · EqualOcean
Recently, jingtaike, a provider of overall solutions for in vitro diagnostics in China, completed a round of financing of tens of millions of yuan PREA exclusively invested by Yuansheng venture capital. This is the first time that the company has accepted external investment, and Qingjie capital acts as a financial adviser. This round of financing will be used for the upgrading of microfluidic PCR adhesive strip demonstration production line, the registration and certification of microfluidic PCR equipment and reagents, the small-scale pilot of grass-roots nucleic acid detection, and the pilot scale mass production of the first generation electrochemical detection equipment and general detection reagents / consumables.

This text is a result of machine translation.